Stanley-Laman Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-316,933
| Closed | -$4.3M | – | 229 |
|
|
2020
Q2 | $4.3M | Sell |
316,933
-2,140
| -0.7% | -$29.1K | 1.04% | 32 |
|
|
2020
Q1 | $2.42M | Buy |
319,073
+6,464
| +2% | +$49K | 0.73% | 41 |
|
|
2019
Q4 | $1.98M | Hold |
312,609
| – | – | 0.47% | 58 |
|
|
2019
Q3 | $1.23M | Hold |
312,609
| – | – | 0.3% | 97 |
|
|
2019
Q2 | $1.51M | Hold |
312,609
| – | – | 0.36% | 78 |
|
|
2019
Q1 | $2.56M | Sell |
312,609
-21,719
| -6% | -$178K | 0.62% | 43 |
|
|
2018
Q4 | $1.85M | Buy |
334,328
+33,146
| +11% | +$183K | 0.51% | 60 |
|
|
2018
Q3 | $2.66M | Sell |
301,182
-40,307
| -12% | -$356K | 0.65% | 42 |
|
|
2018
Q2 | $3.41M | Buy |
341,489
+27,088
| +9% | +$270K | 0.77% | 36 |
|
|
2018
Q1 | $3M | Buy |
+314,401
| New | +$3M | 0.68% | 41 |
|